The effects of hormonal contraceptive use among women with viral hepatitis or cirrhosis of the liver: a systematic review

Contraception

Volumn 80, Issue 4, 2009, Pages 381-386

  Kapp, Nathalie ^a   Tilley, Ian B ^b   Curtis, Kathryn M ^c  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Cirrhosis; Hepatitis; Hormonal contraception; Liver disease; Oral contraception

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ETHINYLESTRADIOL; MESTRANOL; ORAL CONTRACEPTIVE AGENT;

ACUTE HEPATITIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; COCHRANE LIBRARY; DISEASE COURSE; DISEASE SEVERITY; DRUG SAFETY; FEMALE; HEPATITIS B VIRUS; HORMONAL CONTRACEPTION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; MEDICAL LITERATURE; MEDLINE; REVIEW; SYSTEMATIC REVIEW; VIRUS HEPATITIS;

CONTRACEPTIVES, ORAL, COMBINED; DISEASE PROGRESSION; FEMALE; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER CIRRHOSIS; RISK; RISK FACTORS;

EID: 69949168395     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2009.04.007     Document Type: Review

References (20)

1. World Health Organization. Epidemic and pandemic alert and response: hepatitis (2002), WHO, Geneva
2. Hyams K.C. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infec Dis 20 (1995) 992-1000
3. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepatitis 11 (2004) 97-107
4. Kuhl H. Effects of progestogens on haemostasis. Maturitas 24 (1996) 1-19
5. Winkler U.H. Effects of androgens on haemostasis. Maturitas 24 (1996) 147-155
6. Sitruk-Ware R. Pharmacological profile of progestins. Maturitas 47 (2004) 277-283
7. Shaamsh A.H., Salem H.T., Shaaban M.M., Ghaneima S.A., and Helal S.R. Effect of uniplant on liver function in Egyptian women with asymptomatic hepatitis B virus infection. Afr J Reprod Health 9 (2005) 24-31
8. Harris R.P., Helfand M., Woolf S.H., et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 20 3 Suppl (2001) 21-35
9. Mohllajee A.P., Curtis K.M., Flanagan R.G., Rinehart W., Gaffield M.L., and Peterson H.B. Keeping up with evidence: a new system for WHO's evidence-based family planning guidance. Am J Prev Med 28 (2005) 483-490
10. Schweitzer I.L., Weiner J.M., McPeak C.M., and Thursby M.W. Oral contraceptives in acute viral hepatitis. JAMA 233 (1975) 979-980
11. Wang P., Lai Z., Tang J., Xu W., Mi X., and Ma F. Safety of hormonal steroid contraceptive use for hepatitis B virus carrier women. Pharmacoepidem Drug Saf 9 (2000) 245-246
12. Eisalo A., Konttinen A., and Hietala O. Oral contraceptives after liver disease. Br Med J 3 (1971) 561-562
13. Shaaban M.M., Hammad W.A., Fathalla M.F., et al. Effects of oral contraception on liver function tests and serum proteins in women with past viral hepatitis. Contraception 26 (1982) 65-74
14. Di Martino V., Lebray P., Myers R.P., et al. Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology 40 (2004) 1426-1433
15. Libbrecht L., Craninx M., Nevens F., Desmet V., and Roskams T. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis. Histopathology 39 (2001) 66-73
16. Rautio A., Sotaniemi E.A., Pelkonen R.O., and Luoma P.V. Treatment of alcoholic cirrhosis with enzyme inducers. Clin Pharmacol Ther 28 (1980) 629-637
17. Sotaniemi E.A., Hynnynen T., Ahlqvist J., Ahokas J.T., Puoskari U., and Pelkonen I. Effects of medroxyprogesterone on the liver function and drug metabolism of patients with primary biliary cirrhosis and chronic active hepatitis. J Med 9 (1978) 117-128
18. Kremer A., Rios B., Bruno M., and Heinrichs G. Use of medroxyprogesterone in human hepatic cirrhosis. Acta Gastroenterol Latinoam 15 (1985) 25-31
19. Guattery J.M., Faloon W.W., and Biery D.L. Effect of ethinyl estradiol on chronic active hepatitis. Ann Intern Med 126 (1997) 88
20. Guattery J.M., and Faloon W.W. Effect of estradiol upon serum enzymes in primary biliary cirrhosis. Hepatology 7 (1987) 737-742